ENTITY

Mabwell (Shanghai) Bioscience (2493 HK)

1
Analysis
Health CareChina
Mabwell (Shanghai) Bioscience is a biopharmaceutical company focused on the research, development, production, and sales of therapeutic biological products, including macromolecular drugs, therapeutic monoclonal antibodies, and long-acting recombinant proteins. The company's pipeline addresses therapeutic areas such as oncology, autoimmunity, anti-infectives, and ophthalmology. It was founded in 2017 and is headquartered in Shanghai, China.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x